• Economie
• Financiën
• Vastgoed
• Vacatures
• ICT
• Marketing
• Wonen
• Lifestyle
• Cultuur
• Groene tips
• Events
• Hotels/Restaurant
• Recreatie
• Zorg
• BusinessPortHolland
• Sustainable value
• Wetenschap/Innovatie
• Internet /Social media
• Jong blijven/Beauty
• Sport
• Natuur/Adventure
• Vakantie/Travel

Sex drugs voor vrouwen Dual Gezondheidsnieuws

-

Sex Drugs voor vrouwen.
Sex Drugs and Dual control Wetenschappelijk Nieuws
Jos Bloemers onderzoek en lustpil

Pil voor lustgevoelens die vrouwen moet helpen de relatie te stimuleren en weer zin in sex te hebben. De video vertelt hoe het werkt.

Adriaan Tuiten, PhD, established Emotional Brain as a center for clinical and scientific research and education in the field of innovation in healthcare, with a specific focus on womens sexual health. The company is privately owned and currently employs 35 highly skilled professionals.
Emotional Brain has unique expertise in Female Sexual Dysfunction (FSD) and conducts research into the causes of FSD and the development of two new drugs.
Emotional Brain is incorporated in the Netherlands and in the USA. Emotional Brain in the Netherlands is based in Almere, where our subsidiary research unit EB FSD conducts fundamental scientific research into the causes of FSD and clinical research into FSD treatment options (for more information, please refer to www.lybrido.nl). Emotional Brain in the US is based in New York (Emotional Brain New York LLC) and currently conducts Phase IIB studies on the safety and efficacy of Lybrido and Lybridos.
In addition, Emotional Brain has an academic partnership with Utrecht University and runs a PhD program for 5 doctoral students (Medicine and Psychology). Despite a relatively small core teaching staff base, Emotional Brain offers a dynamic research culture with visiting scholars, public lectures and conferences, and a regular program of research seminars.


Press contacts
For further details about Emotional Brain, please complete the contact form on the left, stating any specific questions you may have. Once your form has been submitted, we will contact you as soon as possible.


Visiting addresses:
Emotional Brain BV
Louis Armstrongweg 78
1311 RL Almere
The Netherlands
Emotional Brain direct...

Emotional Brain New York LLC
28 Chesapeake Landing
Annapolis, MD 21403
USA
Tel.: +31 (0)36 546 83 46
For information about business opportunities,
Fax: +31 (0)36 549 71 86
please contact
Email: info@emotionalbrain.nl Email:businessdevelopment@emotionalbrain.nl


The results of the various experiments described in these articles show that the conclusion is justified that there are, indeed, differences in the way sexual stimuli are processed in the brains of individual women. Furthermore, these differences seem to originate from different causes. Whereas in one subgroup, relative insensitivity to sexual stimuli seems congenital, the sexual inhibition in the other subgroup seems to be caused by a combination of brain-related factors and the subjects sexual history.


EB Publications
Pharmacokinetics of a Prototype Formulation of Sublingual Testosterone and a Buspirone Tablet, Versus an Advanced Combination Tablet of Testosterone and Buspirone in Healthy Premenopausal Women. van Rooij K, de Leede L, Frijlink HW, Bloemers J, Poels S, Koppeschaar H, Olivier B, Tuiten A. Drugs R D. 2014 May 22. [Epub ahead of print]
http://link.springer.com/article/10.1007/s40268-014-0047-7
__________________________________________________________________________________
Bloemers J, Scholte HS, van Rooij K, Goldstein I, Gerritsen J, Olivier B, Tuiten A. Reduced Gray Matter Volume and Increased White Matter Fractional Anisotropy in Women with Hypoactive Sexual Desire Disorder. Journal of Sexual Medicine. Published online 2 December 2013
http://onlinelibrary.wiley.com/doi/10.1111/jsm.12410/abstract
__________________________________________________________________________________
Bloemers J, van Rooij K, Poels S, Goldstein I, Everaerd W, Koppeschaar H, Chivers M, Gerritsen J, van Ham D, Olivier B, Tuiten A.Toward Personalized Sexual Medicine (Part 1): Integrating the Dual Control Model into Differential Drug Treatments for HSDD and FSAD. Journal of Sexual Medicine 2013;10 (3):791-809.
__________________________________________________________________________________

Poels S, Bloemers J, van Rooij K, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, Tuiten A. Toward Personalized Sexual Medicine (Part 2): Testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues. Journal of Sexual Medicine 2013;10 (3):810-823.
__________________________________________________________________________________
van Rooij K, Poels S, Bloemers J, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, Tuiten A. Toward Personalized Sexual Medicine (Part 3): Testosterone combined with a serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms. Journal of Sexual Medicine 2013;10 (3):824-837.
__________________________________________________________________________________
van Rooij K, Bloemers J, de Leede L, Goldstein I, Lentjes E, Koppeschaar H, Olivier B, Tuiten A. Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women. Psychoneuroendocrinology 2012;37(6):773-81.
__________________________________________________________________________________
Bloemers J, Gerritsen J, Bults R, Koppeschaar H, Everaerd W, Olivier B, Tuiten A. Induction of sexual arousal in women under conditions of institutional and ambulatory laboratory circumstances: a comparative study. Journal of Sexual Medicine 2010; 7(3):1160-76
__________________________________________________________________________________
Gerritsen J, van der Made F, Bloemers J, van Ham D, Kleiverda G, Everaerd W, Olivier B, Levin R, Tuiten A. The clitoral photoplethysmograph: a new way of assessing genital arousal in women. Journal of Sexual Medicine 2009;6(6):1678-87
__________________________________________________________________________________
van der Made F, Bloemers J, van Ham D, El Yassem W, Kleiverda G, Everaerd W, Olivier B, Tuiten A. Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual dysfunction: a pilot study. Journal of Sexual Medicine 2009;6(2):429-39
__________________________________________________________________________________
van der Made F, Bloemers J, Yassem WE, Kleiverda G, Everaerd W, van Ham D, Olivier B, Koppeschaar H, Tuiten A. The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction. Journal of Sexual Medicine 2009;6(3):777-90
__________________________________________________________________________________
Tuiten A, van Honk J, Verbaten R, Laan E, Everaerd W, Stam H. Can sublingual testosterone increase subjective and physiological measures of laboratory-induced sexual arousal? Archives of General Psychiatry, 2002; 59:465466.
__________________________________________________________________________________
Tuiten A, van Honk J, Koppeschaar H, Bernaards C, Thijssen J, Verbaten R. Time course of effects of testosterone administration on sexual arousal in women. Archives of General Psychiatry 2000;